Font Size: a A A

Parkin interacts with the 26S proteasome via Rpn13, a novel ubiquitin receptor

Posted on:2012-02-18Degree:M.ScType:Thesis
University:McGill University (Canada)Candidate:Aguileta, Miguel AngelFull Text:PDF
GTID:2454390008491783Subject:Biology
Abstract/Summary:
Mutations in the Parkin gene cause a juvenile-onset for of Parkinson's disease (PD) that is transmitted in an autosomal recessive way. Studies have shown that mutations in parkin account for almost 50% of all juvenile-onset forms of PD, making parkin one of the most studied genes as a causative factor for PD.;Studies have shown that parkin functions as a RING type Ub ligase, thus targeting potentially toxic proteins for degradation in the UPP. Parkin's E3 ligase activity is linked to its C-terminal RING1-IBR-RING2 domain. However, the function of its N-terminal ubiquitin-like domain (Ubl) remains unclear. Here, we present evidence suggesting that parkin's Ubl domain mediates an interaction between parkin and the proteasome, specifically Rpn13, a novel ubiquitin receptor.;Ubiquitin (Ub), a small 76 amino acid protein, can be covalently attached to other proteins. This post-translational modification is used as a signal for degradation in the ubiquitin-proteasome pathway (UPP). Ubiquitination requires the concerted activity of 3 basic enzymes: Ub-activaying enzyme (E1), Ub-conjugating enzyme (E2) and Ub-ligase (E3).
Keywords/Search Tags:Parkin, Ubiquitin
Related items